The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes

Figure 2

(a) ROC curve analysis of 5-year biochemical recurrence (BCR) in the DB cohort (n=151) of the CAPRAP score versus the CAPRA & PDE4D7 logistic regression model which was developed on the RP patient cohort with complete 5-year follow-up (n=449). (b) Subcohort ROC curve analysis of the 5-year biochemical recurrence (BCR) of CAPRA & PDE4D7 logistic regression model compared to the CAPRA model alone. In this analysis, only patients with a biopsy Gleason ≥7 were included (n=74).

(a)

(b)